Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India Private Limited, Registrar and Transfer Agent about loss of share certificates on March 11, 2021 Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analysts / Institutional Investors meeting under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the virtual Investor Conference hosted by Valorem Advisors on Monday, March 8, 2021 to discuss the normal course of business activities. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Schedule of Analysts / Institutional Investors meeting held on February 15, 2021 regarding the financial performance of the Company for the quarter ended December 31, 2020 We hereby enclose the Transcript of conference call with Analysts / Institutional Investors held on Monday, February 15, 2021 at 11:00 a.m. (IST) regarding the financial performance of the Company for the quarter ended December 31, 2020. The above Transcript shall also be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to the provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Fermenta Biotech Ltd - 506414 - Publication Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020 In Newspapers
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated February 11, 2021 regarding declaration of Un-audited Financial Results for the quarter and nine months ended December 31, 2020, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai (English version) on page no. 11 and in Sakal, Mumbai (Marathi version) on page no. 9 dated February 12, 2021 for your reference and record. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Investor Relations Presentation - February 2021 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for February 2021 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly take the same on records. Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Presentation For Quarter 3 - Financial Year 2020-2021
Further to our intimation dated February 11, 2021 regarding approval of un-audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2020, we hereby enclose a copy of Earnings Presentation for Quarter 3 - Financial Year 2020-2021. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Kindly take the same on record. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Monday, February 15, 2021 at 11:00 a.m. (IST) to discuss the financial performance of the Company for the quarter ended December 31, 2020. The invite for the said conference call is enclosed herewith. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company. Fermenta Biotech Ltd - 506414 - Financial Results For The Quarter And Nine Months Ended December 31, 2020 (Standalone And Consolidated)
We write to inform you that the Board of Directors of the Company at its meeting held on February 11, 2021 has, inter alia: (a) approved the unaudited financial results for the quarter and nine months ended December 31, 2020 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated February 11, 2021 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP; and (b) approved and authorized to make an application to National Stock Exchange of India Limited ('NSE') seeking listing and trading of equity shares of the Company on the stock exchange platform of NSE through a direct listing route. Kindly take the above on record. The Board meeting commenced at 12 noon and concluded at 1:45 p.m. Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
We write to inform you that the Board of Directors of the Company at its meeting held on February 11, 2021 has, inter alia: (a) approved the unaudited financial results for the quarter and nine months ended December 31, 2020 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated February 11, 2021 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP; and (b) approved and authorized to make an application to National Stock Exchange of India Limited ('NSE') seeking listing and trading of equity shares of the Company on the stock exchange platform of NSE through a direct listing route. Kindly take the above on record. The Board meeting commenced at 12 noon and concluded at 1:45 p.m. Fermenta Biotech Ltd - 506414 - Publication Of Notice Of The Meeting Of Board Of Directors Scheduled On February 11, 2021
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated February 03, 2021 (sent through BSE website) regarding meeting of the Board of Directors of the Company scheduled on February 11, 2021, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 6 and Sakal, Mumbai (Marathi version) on page no. 7 dated February 04, 2021 for your reference and record.